Manufacturers should exhibit that any new technology or technique not only satisfies the existing standards for sterility assurance and also presents tangible Advantages in terms of efficiency, dependability, or product basic safety. As these new systems arise, the WHO emphasizes the importance of a radical chance evaluation and validation p